This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Why “reprogramming” is the buzziest approach to reversing aging right now Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first…
The 2-year-old OpenAI rival, founded by former DeepMind and Meta researchers, develops open-source language models and Le Chat, its AI chatbot built for European audiences.
My business is profitable, stable and 25 years strong — but it has no transferable value. Here’s why some successful companies just aren’t built to sell and why that’s not always a problem.